Fisher & Paykel Healthcare Corporation Limited (OTCPK:FSPKF) Q2 2026 Earnings Call November 25, 2025 4:00 PM EST
Company Participants
Marcus Driller – Vice President of Corporate
Lewis Gradon – MD, CEO & Executive Director
Lyndal York – Chief Financial Officer
Justin Callahan – VP of Sales & Marketing
Conference Call Participants
Lyanne Harrison – BofA Securities, Research Division
Dan Hurren – MST Financial Services Pty Limited, Research Division
Stephen Ridgewell – Craigs Investment Partners Limited, Research Division
Davinthra Thillainathan – Goldman Sachs Group, Inc., Research Division
Vanessa Thomson – Jefferies LLC, Research Division
Matt Montgomerie – Forsyth Barr Group Ltd., Research Division
Craig Wong-Pan – RBC Capital Markets, Research Division
Saul Hadassin – Barrenjoey Markets Pty Limited, Research Division
Marcus Curley – UBS Investment Bank, Research Division
Andrew Paine – CLSA Limited, Research Division
Adrian Allbon – Jarden Limited, Research Division
David Bailey – Morgan Stanley, Research Division
Christine Trinh – Macquarie Research
Presentation
Operator
Welcome to Fisher & Paykel Healthcare’s Results Conference Call. My name is Lisa, and I’ll be your operator for today’s call. [Operator Instructions] Please note, this conference call is being recorded. I’d now like to turn the call over to Marcus Driller, VP Corporate.
Marcus Driller
Vice President of Corporate
Thank you, Lisa. Well, good morning, everyone, and welcome to the conference call for Fisher & Paykel Healthcare’s First Half Results for the 2026 financial year. On the call today are Lewis Gradon, Managing Director and Chief Executive Officer; Lyndal York, Chief Financial Officer; Andy Niccol, Chief Operating Officer; Justin Callahan, VP, Sales and Marketing; and Andrew Somervell, VP of Products and Technology. Lewis and Lyndal will first provide an overview of the results, and then we’ll move on to questions. We’ll be discussing our results for the 6 months ended 30 September 2025. Earlier today, we provided our 2026 interim report, including financial statements and commentary on our results to the NZX and ASX. These disclosures can be accessed on our website. With that, I’d now like to turn the call over to Lewis.
Read the full article here
